BRIEF published on 04/16/2024 at 13:05, 2 years 5 months ago CureVac et MD Anderson collaborent sur des vaccins innovants contre le cancer Technologie ARNm CureVac MD Anderson Vaccins Contre Le Cancer Collaboration Biopharmaceutique
PRESS RELEASE published on 04/16/2024 at 13:00, 2 years 5 months ago CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines CureVac and MD Anderson announce strategic collaboration to develop mRNA-based cancer vaccines, leveraging respective expertise to address unmet medical needs in hematological and solid tumors Clinical Research Collaboration CureVac MD Anderson MRNA-based Cancer Vaccines
BRIEF published on 04/04/2024 at 13:05, 2 years 5 months ago CureVac Reports Positive Phase 2 Results for Influenza Vaccine in Collaboration with GSK GSK MRNA Technology CureVac Influenza Vaccine Phase 2 Trial
BRIEF published on 04/04/2024 at 13:05, 2 years 5 months ago CureVac annonce des résultats positifs de phase 2 pour son vaccin contre la grippe en collaboration avec GSK GSK Technologie ARNm CureVac Vaccin Contre La Grippe Essai De Phase 2
PRESS RELEASE published on 04/04/2024 at 13:00, 2 years 5 months ago CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK CureVac announces positive Phase 2 interim results for seasonal influenza vaccine in collaboration with GSK, showing strong antibody titers and safety profile GSK CureVac Phase 2 Seasonal Influenza Vaccine MRNA
PRESS RELEASE published on 11/01/2023 at 13:00, 2 years 10 months ago CureVac Announces Solid Progress in Phase 2 COVID-19 and Seasonal Flu Clinical Development Programs in Collaboration with GSK
PRESS RELEASE published on 09/28/2023 at 13:00, 2 years 11 months ago CureVac Reports Progress in Intellectual Property Infringement Case Against BioNTech in Germany
PRESS RELEASE published on 09/12/2023 at 13:15, 3 years ago CureVac Advances Seasonal Flu Study to Phase 2 in Collaboration with GSK Following Selection of Promising mRNA Vaccine Candidate with Broad Coverage
PRESS RELEASE published on 09/12/2023 at 13:00, 3 years ago CureVac Advances Seasonal Flu Study to Phase 2 in Collaboration with GSK Following Selection of Promising mRNA Vaccine Candidate with Broad Coverage
PRESS RELEASE published on 08/17/2023 at 13:00, 3 years 1 month ago CureVac Announces Financial Results for the Second Quarter and First Half of 2023 and Provides Business Update
Published on 09/19/2026 at 00:55, 2 days 9 hours ago Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 22:00, 2 days 12 hours ago Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 2 days 13 hours ago Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 2 days 19 hours ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/21/2026 at 09:40, 26 minutes ago EQS-Adhoc: Deutsche Bank to issue Additional Tier 1 capital instruments
Published on 09/21/2026 at 09:35, 31 minutes ago Circus SE: CEO Nikolas Bullwinkel to Speak at Goldman Sachs and Bank of America Stages – Keynotes at Further Investor Conferences
Published on 09/21/2026 at 09:35, 31 minutes ago Comarch Named a Leader in the 2026 IDC MarketScape for Worldwide Compliant E-Invoicing Solutions
Published on 09/21/2026 at 09:00, 1 hour 6 minutes ago Original-Research: Gallmetzer HealthCare SpA (von NuWays AG): BUY
Published on 09/21/2026 at 09:00, 1 hour 6 minutes ago PAINTS AND CHEMICAL INDUSTRIES COMPANY S.A.E. - Removal
Published on 09/21/2026 at 07:00, 3 hours 6 minutes ago Peugeot Invest takes a stake in Mérieux NutriSciences
Published on 09/21/2026 at 07:00, 3 hours 6 minutes ago Peugeot Invest entre au capital de Mérieux NutriSciences
Published on 09/18/2026 at 18:34, 2 days 15 hours ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/18/2026 at 18:34, 2 days 15 hours ago Déclaration hebdomadaire d'opérations effectuées du 14 au 18 septembre 2026
